Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Angelika Andrzejewska-Romanowska, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5874-5874
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cannabinoids and Cannabinoid Receptors: The Story so Far
Fred Shahbazi, Victoria Grandi, Abhinandan Banerjee, et al.
iScience (2020) Vol. 23, Iss. 7, pp. 101301-101301
Open Access | Times Cited: 161
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 90
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 103
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 7
What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?
Piotr Schulz, Szymon Hryhorowicz, Anna Maria Rychter, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 373-373
Open Access | Times Cited: 37
The endocannabinoid system – current implications for drug development
Christopher J. Fowler
Journal of Internal Medicine (2020) Vol. 290, Iss. 1, pp. 2-26
Open Access | Times Cited: 34
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
Jakub Jakowiecki, Renata Abel, Urszula Orzeł, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2456-2456
Open Access | Times Cited: 31
Novel approaches and current challenges with targeting the endocannabinoid system
Paula Morales, Nadine Jagerovic
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 8, pp. 917-930
Open Access | Times Cited: 30
Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015–2019)
Erinn C. Cameron, Samantha L. Hemingway
Journal of Cannabis Research (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 30
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy
Sumanta Garai, Luciana M. Leo, Anna-Maria Szczesniak, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8104-8126
Closed Access | Times Cited: 27
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Mendhi Henna Dasram, Roderick B. Walker, Sandile M. Khamanga
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13223-13223
Open Access | Times Cited: 16
A Comprehensive Review and Update on Cannabis Hyperemesis Syndrome
Priyadarshini Loganathan, Mahesh Gajendran, Hemant Goyal
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1549-1549
Open Access | Times Cited: 3
The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders
Qing Xin, Fei Xu, Devin H. Taylor, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 12, pp. 1507-1518
Open Access | Times Cited: 24
The Cannabinoid CB1 Receptor in Schizophrenia
Faith Borgan, Michelle Kokkinou, Oliver Howes
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 6, pp. 646-659
Closed Access | Times Cited: 21
On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors
Mariangela Pucci, Elizabeta Zaplatić, Maria Vittoria Micioni Di Bonaventura, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 398-398
Open Access | Times Cited: 18
Targeting the endocannabinoid system in diabesity: Fact or fiction?
Farah Deeba, Ashish Kumar, Monalisa Mukherjee, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1750-1758
Closed Access | Times Cited: 14
Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor
Francesca Gado, Kawthar A. Mohamed, Serena Meini, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113116-113116
Closed Access | Times Cited: 14
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
Ivona Maria Tudorancea, Mitică Ciorpac, Gabriela Dumitrița Stanciu, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2492-2492
Open Access | Times Cited: 8
Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB
Alexander Hamilton, Alan D. Payne, Mauro Mocerino, et al.
Australian Journal of Chemistry (2021) Vol. 74, Iss. 6, pp. 416-432
Open Access | Times Cited: 10
Molecular basis for ligand modulation of the cannabinoid CB1 receptor
Karthik Ramesh, Daniel M. Rosenbaum
British Journal of Pharmacology (2021) Vol. 179, Iss. 14, pp. 3487-3495
Open Access | Times Cited: 10
Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569
AyoOluwa O. Aderibigbe, Pankaj Pandey, Robert J. Doerksen
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 13, pp. 5729-5747
Open Access | Times Cited: 6
Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment
Ava Bachari, Nazim Nassar, Ellen Schanknecht, et al.
WIREs Mechanisms of Disease (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
Asher L. Brandt, Sumanta Garai, Ayat Zagzoog, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
GPCR Signaling: A Study of the Interplay Between Structure, Energy, and Function
Yann Chalopin
Proteins Structure Function and Bioinformatics (2024) Vol. 92, Iss. 12, pp. 1385-1397
Closed Access
Chemical Probes for Investigating the Endocannabinoid System
Annaleah Hanske, Marc Nazaré, Uwe Grether
Current topics in behavioral neurosciences (2024)
Closed Access
Page 1 - Next Page

Scroll to top